OverviewSuggest Edit

Galenica is a healthcare services and products provider, that operates three business sectors: retail, products and brands, and services. The Company manages a locally established pharmacies network in Switzerland, develops and distributes its own product portfolio, as well as cooperates with business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution a range of brands. 

TypePublic
Founded1927
HQBern, CH
Websitegalenica.com
Employee Ratings3.7

Latest Updates

Employees (est.) (Sept 2020)5,379(+29%)
Job Openings121
Share Price (Oct 2020)CHF59.8
Cybersecurity ratingAMore

Key People/Management at Galenica

Daniela Bosshardt

Daniela Bosshardt

Chairwoman of the Board of Directors
Marc Werner

Marc Werner

CEO
Felix Burkhard

Felix Burkhard

CFO
Bertrand Jungo

Bertrand Jungo

Vice-Chairman of the Board of Directors
Show more

Galenica Office Locations

Galenica has an office in Bern
Bern, CH (HQ)
8 Untermattweg
Show all (1)

Galenica Financials and Metrics

Galenica Revenue

Market capitalization (23-Oct-2020)

2.9b

Closing stock price (23-Oct-2020)

59.8
Galenica's current market capitalization is CHF2.9 b.
Show all financial metrics

Galenica Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

SecurityScorecard logo

Galenica Online and Social Media Presence

Embed Graph

Galenica Blogs

2020 Annual General Meeting of Galenica Ltd.

3rd Annual General Meeting of Galenica Ltd.: Shareholders approved all proposals and elected Pascale Bruderer as a new member of the Board of Directors

Sustainability report 2019: innovation further strengthens patient safety and health

The Galenica Group’s business activities have an economic, social and ecological impact throughout the entire value chain of the healthcare market. Sustainability is an integral part of Galenica’s corporate management, and the sustainability report 2019 shows how measures are implemented and what ha…

The protection of patients and employees is Galenica’s top priority

In recent weeks, under the most difficult and unique circumstances, Galenica has made every effort to ensure the supply of medicines and healthcare products to the Swiss population.

Update on the COVID-19 situation

Galenica will hold its Annual General Meeting without shareholder presence and is proposing a dividend payment as announced

Federal Council decision on the limited dispensing of selected medicines

Galenica welcomes the decision of the Federal Council from 18 March 2020 to limit the dispensing of selected medicines. This will relieve the burden on the supply chain and ensure that basic supplies can continue to be provided in a timely manner, so that priority can be given to supplying medicines…

Verfora is reintroducing Vita-Merfen®

Verfora will supply Vita-Merfen®, the well-known and much loved brand for disinfection and wound healing, to Swiss pharmacies and drugstores again towards the end of 2020.
Show more

Galenica Frequently Asked Questions

  • When was Galenica founded?

    Galenica was founded in 1927.

  • Who are Galenica key executives?

    Galenica's key executives are Daniela Bosshardt, Marc Werner and Felix Burkhard.

  • How many employees does Galenica have?

    Galenica has 5,379 employees.

  • Who are Galenica competitors?

    Competitors of Galenica include Amgen, mPharma and BioRx.

  • Where is Galenica headquarters?

    Galenica headquarters is located at 8 Untermattweg, Bern.

  • Where are Galenica offices?

    Galenica has an office in Bern.

  • How many offices does Galenica have?

    Galenica has 1 office.